Clinical Trials Logo

Clinical Trial Summary

The clinical trial is planned to investigate the efficacy and safety of acetylated natural nucleotides in treating anti-cancer medications induced hand-foot syndrome (HFS).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04592731
Study type Interventional
Source Shanghai East Hospital
Contact
Status Completed
Phase N/A
Start date November 3, 2020
Completion date June 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT05755646 - Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial N/A
Completed NCT00446147 - Study of Pyridoxine for Hand-Foot Syndrome Phase 3
Completed NCT01609166 - Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome Phase 2
Terminated NCT03173365 - The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients Phase 2
Recruiting NCT04979078 - Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction N/A
Recruiting NCT05165069 - The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome Phase 3
Recruiting NCT05348278 - Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome Phase 2/Phase 3
Recruiting NCT04833998 - Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine Phase 2
Not yet recruiting NCT05949307 - The Efficacy of Acupuncture and Laser Acupuncture in Treating Chemotherapy or Target Therapy-induced Hand-foot Syndrome N/A